Literature DB >> 11132463

Celiac disease in India.

B R Thapa1.   

Abstract

Celiac disease is well documented especially from northern parts of India. It should be suspected in a child having chronic diarrhoea with growth failure. There are unusual manifestations like refractory anemia, rickets, recurrent abdominal pain and short stature without other gastrointestinal manifestations. Definitive diagnosis still requires undertaking multiple intestinal biopsies, before and after wheat withdrawal from the diet. Additional difficulty in diagnosing celiac in tropical countries like India includes confounding factors of malnutrition and parasitic infestations like giardia. Serological tests like antigliadin antibodies (IgG and IgA), anti-reticulin antibodies and endomysial antibodies have shown some promise in screening and definitive evaluation of the disease. Gluten free diet gives dramatic results.

Entities:  

Mesh:

Year:  1999        PMID: 11132463

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  4 in total

1.  Assessment of dietary compliance to gluten free diet and psychosocial problems in Indian children with celiac disease.

Authors:  J C Chauhan; Praveen Kumar; A K Dutta; Srikanta Basu; Arun Kumar
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

2.  Assessment of sexual maturity in a cohort of adolescents with celiac disease on gluten-free diet.

Authors:  Kirtisudha Mishra; Praveen Kumar; Rajesh Kumar; Sharandeep Kaur; Srikanta Basu; Ashok Kumar Dutta
Journal:  Indian J Gastroenterol       Date:  2012-06-19

3.  Celiac disease with splenic calcifications.

Authors:  Anu Maheshwari; Satinder Aneja; Praveen Kumar; Shreshtha Banga
Journal:  Indian J Pediatr       Date:  2010-12-03       Impact factor: 1.967

Review 4.  Celiac disease in the developing countries: a new and challenging public health problem.

Authors:  Francesco Cataldo; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.